Cargando…

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors

PURPOSE: To unravel the oncogenic role of CDCA4 in different cancers from the perspective of tumor immunity. METHODS: Raw data on CDCA4 expression in tumor samples and paracancerous samples were obtained from TCGA and GTEX databases. In addition, we investigated pathological stages and the survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Hui, Sheng, Shuyan, Chen, Bangjie, Wang, Jianpeng, Mao, Deshen, Han, Yanxun, Liu, Yuchen, Wang, Xinyi, Gui, Siyu, Zhang, Tongyuan, Zhang, Lizhi, Li, Conghan, Hu, Xinyang, Deng, Wanyu, Liu, Xin, Xu, Honghai, Xu, Wentao, Wang, Xingyu, Liu, Rongqiang, Kong, Weihao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891459/ https://www.ncbi.nlm.nih.gov/pubmed/35251007 http://dx.doi.org/10.3389/fimmu.2022.826337

Ejemplares similares

The role of resveratrol on rheumatoid arthritis: From bench to bedside
por: Sheng, Shuyan, et al.
Publicado: (2022)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

The role of IL-6 in coronavirus, especially in COVID-19
por: Wang, Xinyi, et al.
Publicado: (2022)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

Comparison of various surgical incisions in parotidectomy: A systematic review and network meta-analysis
por: Yin, Siyue, et al.
Publicado: (2022)

An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance
por: Han, Yanxun, et al.
Publicado: (2022)

Interleukin 22 and its association with neurodegenerative disease activity
por: Chen, Wenjian, et al.
Publicado: (2022)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice
por: Chen, Bangjie, et al.
Publicado: (2021)

A Novel Inflammatory Response–Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma
por: Han, Yanxun, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3
por: Liu, Junye, et al.
Publicado: (2021)

Prognostic value of CD169-positive macrophages in various tumors: a meta-analysis
por: Kong, Weihao, et al.
Publicado: (2021)

A New Online Dynamic Nomogram: Construction and Validation of an Assistant Decision-Making Model for Laryngeal Squamous Cell Carcinoma
por: Liu, Yuchen, et al.
Publicado: (2022)

A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
por: Liu, Yuchen, et al.
Publicado: (2023)

KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2021)

KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2023)

Upregulation of miR-29c-3p Hinders Melanoma Progression by Inhibiting CDCA4 Expression
por: Liu, Jiazheng, et al.
Publicado: (2021)

Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression
por: Chen, Bangjie, et al.
Publicado: (2023)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker
por: Gao, Yang, et al.
Publicado: (2023)

Emerging role of different DNA methyltransferases in the pathogenesis of cancer
por: Liu, Pengcheng, et al.
Publicado: (2022)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma
por: Hao, Suyu, et al.
Publicado: (2021)

Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target
por: Wu, Maomao, et al.
Publicado: (2022)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
por: Wang, Xiaoxiong, et al.
Publicado: (2021)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy
por: Xu, Chenxin, et al.
Publicado: (2021)

CDCA7 promotes TGF‐β‐induced epithelial–mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC
por: Li, Hongyi, et al.
Publicado: (2022)

Myeloid cells in alcoholic liver diseases: Mechanism and prospect
por: Xu, Wentao, et al.
Publicado: (2022)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells
por: Xu, Bing, et al.
Publicado: (2021)

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
por: Li, Wenle, et al.
Publicado: (2023)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qc34mmegei29bei8jp4824n061